Building a cross-disciplinary, inspiring scientific community and supporting visionary, early-stage research.

In early 2022 we announced a new cohort of scientists to be named Chan Zuckerberg Biohub Investigators. Successful applicants receive $1 million in unrestricted gift funds over a nonrenewable five-year term ($200,000 per year), with a start date of March 1, 2022.

The Chan Zuckerberg Biohub Investigator Program, open to faculty from Stanford University, UC Berkeley, and UC San Francisco, funds innovative, visionary research with the goal of building engaged, collaborative scientific communities to help solve critical challenges in biomedicine.

The 86 awardees in our new cohort, who were chosen from nearly 700 applicants through a competitive process judged by nationally recognized external reviewers and a blue-ribbon Selection Advisory Committee, represent a diverse range of disciplines, including basic biological sciences, clinical biomedical sciences, physics, chemistry, engineering, computer and data sciences, statistics, and public health. 

We will be announcing the call for applications from faculty members at our partner universities (Stanford, UC Berkeley, UCSF) in early 2026 for five-year awards beginning March 2027.


Below are the scientists in the 2022 cohort of CZ Biohub Investigators. View the full list of Investigators here.

  • Hillel Adesnik, Ph.D. UC Berkeley
  • Jennifer Ahern, Ph.D. UC Berkeley
  • Nicolas Altemose, D.Phil., Ph.D. Stanford University
  • Mark Anderson, M.D., Ph.D. UCSF
  • Katrin Andreasson, M.D. Stanford University
  • Ana Paula Arruda, Ph.D. UC Berkeley
  • Zhenan Bao, Ph.D. Stanford University
  • Jade Benjamin-Chung, Ph.D., M.P.H. Stanford University
  • Trever Bivona, M.D., Ph.D. UCSF
  • Catherine Blish, M.D., Ph.D. Stanford University
  • Anne Brunet, Ph.D. Stanford University
  • Daniele Canzio, Ph.D. UCSF
  • Edward Chang, M.D. UCSF
  • Sarah Chasins, Ph.D. UC Berkeley
  • Charles Chiu, M.D., Ph.D. UCSF
  • Thomas Clandinin, Ph.D. Stanford University
  • Christina Curtis, Ph.D. Stanford University
  • Jose Dinneny, Ph.D. Stanford University
  • Jennifer Dionne, Ph.D. Stanford University
  • Elizabeth Egan, M.D., Ph.D. Stanford University
  • Shirit Einav, M.D. Stanford University
  • Stefano Ermon, Ph.D. Stanford University
  • Michael Fischbach, Ph.D. Stanford University
  • Yvette Fisher, Ph.D. UC Berkeley
  • Daniel Fletcher, Ph.D., D.Phil. UC Berkeley
  • Polly Fordyce, Ph.D. Stanford University
  • Emily Fox, Ph.D. Stanford University
  • Hernan Garcia, Ph.D. UC Berkeley
  • Zev Gartner, Ph.D. UCSF
  • Pascal Geldsetzer, M.D., Ph.D., M.P.H. Stanford University
  • Aaron Gitler, Ph.D. Stanford University
  • Benjamin Good, Ph.D. Stanford University
  • Hani Goodarzi, Ph.D. UCSF
  • Carlos Guestrin, Ph.D. Stanford University
  • Lin He, Ph.D. UC Berkeley
  • Rogelio Hernández-López, Ph.D. Stanford University
  • Amy Herr, Ph.D. UC Berkeley
  • Bo Huang, Ph.D. UCSF
  • Franklin Huang, M.D., Ph.D. UCSF
  • KC Huang, Ph.D. Stanford University
  • Nilah Ioannidis, Ph.D. UC Berkeley
  • Tanja Kortemme, Ph.D. UCSF
  • Britt Koskella, Ph.D. UC Berkeley
  • Diana Laird, Ph.D. UCSF
  • Markita Landry, Ph.D. UC Berkeley
  • Charles Langelier, M.D., Ph.D. UCSF
  • Liana Lareau, Ph.D. UC Berkeley
  • Hao Li, Ph.D. UCSF
  • Aashish Manglik, M.D., Ph.D. UCSF
  • Nicole Martinez, Ph.D. Stanford University
  • Michael McManus, Ph.D. UCSF
  • Shaeri Mukherjee, Ph.D. UCSF
  • Dipti Nayak, Ph.D. UC Berkeley
  • Aaron Newman, Ph.D. Stanford University
  • Oanh Nguyen, M.D. UCSF
  • Elphège Nora, Ph.D. UCSF
  • James Nuñez, Ph.D. UC Berkeley
  • Lucy O'Brien, Ph.D. Stanford University
  • Ziad Obermeyer, M.D. UC Berkeley
  • Melanie Ott, M.D., Ph.D. Gladstone Institutes/UCSF
  • Sergiu Pașca, M.D. Stanford University
  • Dmitri Petrov, Ph.D. Stanford University
  • Amy Pickering, Ph.D. UC Berkeley
  • Katherine Pollard, Ph.D. Gladstone Institutes/UCSF
  • Kira Poskanzer, Ph.D. UCSF
  • Joseph Puglisi, Ph.D. Stanford University
  • Elizabeth Purdom, Ph.D. UC Berkeley
  • Filipa Rijo-Ferreira, Ph.D. UC Berkeley
  • Stanley Qi, Ph.D. Stanford University
  • Roberto Ricardo Gonzalez, M.D., Ph.D. UCSF
  • Isabel Rodríguez-Barraquer, M.D., Ph.D. UCSF
  • Daniel Rokhsar, Ph.D. UC Berkeley
  • Jennifer Rosenbluth, M.D., Ph.D. UCSF
  • Florentine Rutaganira, Ph.D. Stanford University
  • Rada Savic, Ph.D. UCSF
  • Alanna Schepartz, Ph.D. UC Berkeley
  • Seth Shipman, Ph.D. Gladstone Institutes/UCSF
  • Anita Sil, M.D., Ph.D. UCSF
  • Jan Skotheim, Ph.D. Stanford University
  • Mark Skylar-Scott, Ph.D. Stanford University
  • Justin Sonnenburg, Ph.D. Stanford University
  • Teresa Sparks, M.D. UCSF
  • Aaron Streets, Ph.D. UC Berkeley
  • Sara Suliman, Ph.D., M.P.H. UCSF
  • Hawa Racine Thiam, Ph.D. Stanford University
  • Alice Ting, Ph.D. Stanford University
  • Peter Turnbaugh, Ph.D. UCSF
  • Srigokul Upadhyayula, Ph.D. UC Berkeley
  • Daniel Wagner, Ph.D. UCSF
  • Laura Waller, Ph.D. UC Berkeley
  • Arun Wiita, M.D., Ph.D. UCSF
  • Catera Wilder, Ph.D. UCSF
  • Helen Willsey, Ph.D. UCSF
  • Ellen Yeh, M.D., Ph.D. Stanford University
  • Serena Yeung, Ph.D. Stanford University
  • James Zou, Ph.D. Stanford University


The Chan Zuckerberg Biohub (CZ Biohub) is an independent, nonprofit medical research organization that was established in 2016 with the goals of understanding the mechanisms underlying disease and developing new technologies that will enable fresh avenues of scientific discovery and lead to actionable diagnostics and effective therapies. CZ Biohub was conceived and launched in partnership with Stanford University, UC San Francisco, and UC Berkeley to promote close collaboration across the three campuses in pursuit of this mission. CZ Biohub has an intramural research program focused on technology development, cell biology, and infectious disease, and an extramural research program – anchored by the Chan Zuckerberg Biohub Investigator Program – that provides unrestricted funds to faculty members at all three campuses to pursue their most exciting, risky, and innovative ideas.


A foundational goal of the Chan Zuckerberg Biohub Investigator Program is to build and sustain an engaged, interactive, and collaborative community of researchers that spans across disciplines and across the campuses of our three partner universities, Stanford University, UCSF, and UC Berkeley.

The backbone of our community and a primary engine of collaboration is found in the CZ Biohub Investigator meetings. CZ Biohub Investigators are expected to participate fully in the CZ Biohub community by attending at least half of the CZ Biohub Investigator meetings that are held every two weeks.

With the goal of accelerating the pace of scientific discovery, CZ Biohub Investigators are required to upload all manuscripts on which they are a corresponding author to a preprint server such as or upon submission to a peer-reviewed journal. Intellectual property generated with material support from CZ Biohub funding or resources will be jointly owned with the universities; inventor royalty sharing will not be affected and licensing will be led by CZ Biohub with university approval and in direct consultation with the Investigator.


The start date of awards is March 1, 2022.


Applications for Chan Zuckerberg Biohub Investigator Awards are open to faculty members from Stanford University, UCSF, and UC Berkeley who are eligible to serve as a principal investigator for federal and other grants.

We welcome applications from faculty members representing diverse disciplines such as engineering, computer science, mathematics and statistics, the physical sciences, chemistry, clinical and biomedical sciences, public health, and the biological sciences. The scope of investigator research is open to all areas of biology, biomedical research, and technology development, including areas that are well outside the scope of CZ Biohub’s intramural research programs.

CZ Biohub strongly encourages faculty who are at an early stage of their career and faculty from groups underrepresented in science, engineering, and the clinical sciences to apply. CZ Biohub has strived to assemble a highly diverse group of external reviewers to support the review process. Applications from assistant professors will be considered separately from those of associate and full professors.


Access frequently asked questions about the CZ Biohub Investigator Competition. 

FAQ last updated: 4/1/21